Sartorius BIA Separations, Exopharm team for large-scale exosome production
November 23, 2022 -- Bio-chromatography company Sartorius BIA Separations and medicine biopharmaceutical company Exopharm have signed a material transfer agreement in order to meet the demand of improved large-scale therapeutic exosome production and commercialization. Read More
NSF grant awarded to develop membrane purification platform
November 18, 2022 -- University of Kentucky researchers, in collaboration with the University of Arkansas and Clemson University, have received a $1.6 million National Science Foundation (NSF) grant to create a membrane purification platform for large-scale biomanufacturing of viral vectors and virus-like particles. Read More
Drug to treat prostate cancer shows promise
November 28, 2022 -- A single drug compound attacks prostate cancer by triggering immune cells and hinders the tumor's ability to use testosterone as fuel, a new study finds. The drug could be used to treat other solid tumors that don't respond to standard therapy. Read More
Certain protein creates domino effect to set off ALS
November 28, 2022 -- King's College London researchers have found that the loss of a processing protein is likely the molecular trigger in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Read More
PerkinElmer launches viral vector assays to boost gene therapy research
November 22, 2022 -- PerkinElmer has announced the launch of its "ready-to-use" adeno-associated virus vectors detection kits to support researchers working on gene therapies for a variety of diseases. Read More
Multiplexed 'CAR Pooling' accelerates evaluation of anticancer cell therapy receptors
November 14, 2022 -- Researchers have developed a new method for comparing massive numbers of CAR T cells, each with slightly different molecular features, to determine which is most effective and long-lasting against cancer. Read More
Mitochondria seen as common thread in autism spectrum disorder
November 28, 2022 -- Researchers in Canada have discovered previously unknown connections between genetic factors in autism spectrum disorder, specifically with the mitochondria. Read More
Scientists offer way to overcome barriers to nucleic acid delivery
November 23, 2022 -- Scientists from Australia's Monash University have suggested ways of overcoming the challenges in delivering nucleic acid therapeutics, including engineering smart, responsive, and targeted nanoparticle delivery systems. Read More
Omicron subvariants dodge neutralizing antibodies: study
November 28, 2022 -- Three subvariants of SARS-CoV-2 currently sweeping through the U.S. are better at evading vaccine- and infection-generating neutralizing antibodies than earlier versions of the virus, new research finds. Read More
New protein target may help fight COVID-19
November 23, 2022 -- A University of Geneva-led research team revealed a hidden cavity on the surface of a key non-structural SARS-CoV-2 protein. Their research, published November 22 in the journal eLife, may facilitate this cavity’s use as a target for binding therapeutic drugs. Read More
Scripps Research identifies new drugs to cut alcohol use in PTSD survivors
November 21, 2022 -- Scripps Research scientists have identified a class of drugs that decreases alcohol preference and intake as well as other behaviors associated with post-traumatic stress disorder (PTSD), such as aggression, excessive fear, and hyperarousal. Read More
Bio-Rad launches new antibody discovery platform
November 18, 2022 -- Bio-Rad Laboratories has launched the Pioneer Antibody Discover Platform, a new antibody discovery service designed to develop "best-in-class" biologic candidates. Read More
Sequencing project explores euglenoids' biotech potential
November 23, 2022 -- The Euglena International Network has launched a plan to sequence the genomes of all known euglenoid species over the next decade. Read More
CRISPR-Cas9 gene editing links RNA-binding protein to immunotherapy resistance
November 21, 2022 -- Using CRISPR-Cas9 gene editing, Swiss researchers have provided evidence that expression of an RNA-binding protein helps tumors to evade the immune system. Read More
'Immunologic memory' may explain chronic inflammation in HIV: study
November 23, 2022 -- A study by researchers from George Washington University may explain why chronic inflammation occurs in people living with HIV and how suppression or even eradication of the virus may not resolve it. Read More
NIH awards $12M for development of antiviral therapies
November 22, 2022 -- The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), has awarded three institutions more than $12 million for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential. Read More
Researchers discover way to increase synthetic mRNA's protein production
November 23, 2022 -- A team of researchers from the Hong Kong University of Science and Technology has discovered a way to increase synthetic mRNA's protein production efficiency by up to 10 times. They contend that their findings can improve the effectiveness of mRNA vaccines and drugs with even less dosage of the mRNAs. Read More
Proteomic signature improves detection of hard-to-identify form of prediabetes
November 14, 2022 -- Testing for a three-protein signature in the blood could improve the detection of a form of prediabetes, according to research published November 10 in the journal Nature Medicine. Read More
Signal detection enables clear imaging of human cells
November 21, 2022 -- Beckman Institute researchers have developed an innovative method to clearly visualize the structure and chemical composition of a human cell. Read More
New computational method maps architecture of human tissues in unprecedented detail
October 31, 2022 -- Weill Cornell Medicine researchers have developed a new computational method to map the architecture of human tissues in unprecedented detail, with the potential to accelerate studies on organ-scale cellular interactions and enable powerful new diagnostic strategies for an array of diseases. Read More
Science In Brief
Conferences
Cell Bio 2022
December 3-7
District of Columbia United States
December 3-7
District of Columbia United States
Connect
Latest Tweets